Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03382652 · ClinicalTrials.gov registry record
Continuum™ Metal Bearing System in Total Hip Arthroplasty
A clinical trial of Osteoarthritis and Avascular Necrosis, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 83
- Enrollment target
- 3
- Study locations
NCT03382652: Completed study of Osteoarthritis and Avascular Necrosis, sponsored by Zimmer Biomet.
NCT03382652 is a study of Osteoarthritis and Avascular Necrosis that has completed, run by Zimmer Biomet. The registered enrollment target is 83 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03382652, a study of Osteoarthritis and Avascular Necrosis, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
- 3
- Study locations
Study Summary
The study is a multi-center, prospective, non-controlled, consecutive cohort post market surveillance study. The objective of this study is to obtain survival and outcome data on the Continuum Metal Bearing System in primary total hip arthroplasty.
Primary Outcome
The primary endpoint for this study is implant survival at 10 years which was assessed by revision either of the Continuum Cup or the Metasul liner. A success rate for the experimental group was calculated using the Kaplan-Meier Survival Estimation.
Conditions Studied
Interventions
- DEVICE Metal-on-Metal Articulation
Study Locations (3)
Other
- Jokilaakson terveys oy - Jämsä
- Hospital District of Southwest Finland - Turku
Texas
- Saint Davids Medical Center - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2011-02-09 |
| Est. Completion | 2022-10-22 |
What the finished NCT03382652 record still lists
NCT03382652 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (90% lower).
The record links to 5 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Metal-on-Metal Articulation is the first listed.
NCT03382652 reports a single indexed study location in Other, Texas.
Frequently Asked Questions
What is clinical trial NCT03382652 about?
NCT03382652 is a clinical study titled "Continuum™ Metal Bearing System in Total Hip Arthroplasty". The study is a multi-center, prospective, non-controlled, consecutive cohort post market surveillance study. The objective of this study is to obtain survival and outcome data on the Continuum Metal Bearing System in primary total hip arthroplasty.
What is the current status of trial NCT03382652?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2011-02-09. Estimated completion is 2022-10-22.
What conditions does trial NCT03382652 study?
This clinical trial studies the following conditions: Osteoarthritis, Avascular Necrosis, Total Hip Arthroplasty, Inflammatory Arthritis, Post-traumatic; Arthrosis.
What interventions are being tested in trial NCT03382652?
The interventions under investigation include: Metal-on-Metal Articulation (DEVICE).
Who is sponsoring clinical trial NCT03382652?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03382652 being conducted?
This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03382652's enrollment target sits among peer trials
83 97th of 135 higher than 39 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
RECRUITING · Phase 2
-
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
RECRUITING
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
RECRUITING · Phase 4
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI